The causes of the most common permanently disabling birth defect in the United States, spina bifida, are not well understood. And, there is no cure. Nonetheless, preventing spina bifida is the ultimate goal, and that goal is the driving force for several researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology at Houston.
A paper published this month in the Journal of Cellular Biochemistry and the awarding of an international patent chips away at scientific dogma about the nature of sugar molecules.
The Institute of Biosciences and Technology (IBT) at The Texas A&M University System Health Science Center recently received a pledge of $250,000 from the John S. Dunn Research Foundation. The grant funds will purchase a 3-D laser scanning confocal microscope. The new visual imaging instrumentation will enhance IBTs Molecular and Cellular Imaging Facility, which is located within its Center for Cancer Biology and Nutrition.
The Texas Institute for Genomic Medicine announced today that researchers associated with the Institute and Lexicon Genetics Incorporated have discovered that defects in the FKBP8 gene may play a role in spina bifida, a common birth defect affecting the lower spinal column.
The Texas Enterprise Fund has awarded $50 million for the creation of the Texas Institute for Genomic Medicine, a non-profit organization founded by two members of The Texas A&M University SystemThe Texas A&M University System Health Science Center Institute of Biosciences and Technology (IBT) in Houstons Texas Medical Center and Texas A&M University in College Stationand Lexicon Genetics Incorporated in The Woodlands.
The Texas A&M University System Health Science Center Institute of Biosciences and Technology (IBT) recently received a grant of $100,000 from the Neva and Wesley West Foundation. The grant funds will support studies of bacterial infections caused by an antibiotic-resistant form of the Staphylococcus aureus bacteria. IBT is located in Houston in the renowned Texas Medical Center.
Richard H. Finnell, Ph.D., is one of two guest editors of a special issue of American Journal of Medical Genetics, Part C, Seminars in Medical Genetics. This issue is called Neural Tube Defects and is an offshoot of the third International Neural Tube Defects Symposium, held in 2003.
Robert Schwartz, Ph.D., associate director of the Institute of Biosciences and Technology (IBT), is representing The Texas A&M University System Health Science Center at a gathering of national and international specialists that will discuss stem cell research.